In addition, mouse models of MS have shown C3a and C5a to contribute to demyelination, delayed remyelination, worsen disease severity, and being capable of inducing the production of pro-inflammatory cytokines and chemokines [47, 48]. The gene discussed is C5; the disease is myeloid sarcoma.